Adding Ramucirumab To Second-Line Irinotecan, 5-Fluorouracil and Folinic Acid (Folfiri) Treatment for Metastatic Colorectal Carcinoma (Mcrc)- Resource Utilization Data from Raise, A Global, Randomized, Double-Blind, Multicenter Phase 3 Stud ...

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2552
https://www.valueinhealthjournal.com/article/S1098-3015(17)32886-3/fulltext
Title : Adding Ramucirumab To Second-Line Irinotecan, 5-Fluorouracil and Folinic Acid (Folfiri) Treatment for Metastatic Colorectal Carcinoma (Mcrc)- Resource Utilization Data from Raise, A Global, Randomized, Double-Blind, Multicenter Phase 3 Stud ...
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32886-3&doi=10.1016/j.jval.2017.08.2552
First page : A871
Section Title : SELECTED HEALTH CARE TREATMENT STUDIES -MEDICAL DEVICE/DIAGNOSTICS
Open access? : No
Section Order : 2356
Categories :
Tags :
Regions :
ViH Article Tags :